Stem Cell Treatments for Dry Macular Degeneration—Cautious Optimism Advised for Patients

Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued

Stem Cell Treatments for Dry Macular Degeneration—Cautious Optimism Advised for Patients

Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued

Is It Possible to Prevent the Inflammation that Triggers Dry Macular Degeneration? New Research Says Maybe

One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are now a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment remains elusive, although several potential treatments have emerged in recent years. Current … Continued

New Research: The Number of New Cases of Low Vision and Blindness in Adults and Older Adults Is Expected to Double During the Next 30 Years

New research from Johns Hopkins University School of Medicine reveals that the annual number of new cases of blindness and low vision among people aged 45 years and older is estimated to double during the next 30 years. Because data about the incidence of blindness and low vision in the United States was formally estimated … Continued

Why I Have Written Three Series of Articles About My Experience with Macular Hole and Pseudo Macular Hole

by Joy R. Efron, Ed.D.   People have asked why I have written three series of articles about my experiences with macular hole and pseudo macular hole. The simple explanation is that I am attempting to reciprocate—to thank the many people who helped me—by helping others. My impressive visual recovery would not have been possible … Continued

New Research: Two Potential Treatments for Dry Macular Degeneration and Geographic Atrophy

One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment continues to be elusive. Current treatments for dry AMD include a number of … Continued

During Eye Injury Prevention Month: Beware of Cosmetic Contact Lenses and Scleral Tattoos

Every year, during Eye Injury Prevention and Halloween Safety Month, I begin to get questions from friends and colleagues about the safety of decorative (also called “cosmetic,” “circle,” “costume,” or “non-prescription”) contact lenses. For the uninitiated, “circle lenses,” which first became popular in Asia about 10 years ago, are contact lenses that give the wearer … Continued

Can a New Type of Blood Test Identify Macular Degeneration Much Earlier? New Research Says Yes

New research led by the AMD Center of Excellence at Harvard Medical School, the University of Coimbra, Portugal, and Brigham and Women’s Hospital has used an emerging field of study, called “metabolomics” (explained below), to test patients’ blood and identify blood profiles that are associated with age-related macular degeneration (AMD). According to study co-author Joan … Continued

The FDA Officially Cracks Down on Stem Cell Clinics Offering Unproven and Dangerous Treatments

On Monday, August 28, 2017, Scott Gottlieb, M.D., Commissioner of the United States Food and Drug Administration (FDA), announced a crackdown on stem cell clinics offering unproven and potentially dangerous treatments. Commissioner Gottlieb stated that he “will not allow deceitful actors to take advantage of vulnerable patients by purporting to have treatments or cures for … Continued

New Research: Medicaid Recipients with Glaucoma Receive Substantially Less Testing Than Persons with Commercial Health Insurance

Glaucoma often is called “the sneak thief of sight” for good reason: Many people are unaware that glaucoma has few symptoms or warning signs in its early stages. Early treatment for glaucoma can usually (but not always) slow the progression of the disease. However, as of yet, there is no cure for glaucoma. Because glaucoma … Continued